*Naoki Kato¹, Hiroko Bannai¹, Hideyuki Okano², Sumihiro Maeda² (1. School of Advanced Science and Engineering, Waseda University, 2. School of Medicine, Keio University)

*Hiroto Akuta¹, Risako Nakai², Takashi Umehara¹, Natsuki Osaka³, Atsuo Sasaki³, Masayuki Shimada¹, Masanori Imamura², Takuya Imamura¹ (1. rad Sch of Integr Sci for Life, Hiroshima Univ, Hiroshima, Japan, 2. EHUB, Kyoto Univ, Aichi, Japan, 3. IAB, Keio Univ, Yamagata, Japan)

*Kohei Nomaki¹, Risako Fujikawa¹, Takahiro Masuda², Makoto Tsuda¹ (1. Dept. Mol. Syst. Pharmacol., Grad. Sch. Pharm. Sci., Kyushu Univ., 2. Div. Mol. Neuroimmunology, Med. Inst. Bioregulation, Kyushu Univ.)

*Hisa Asai¹, Yuki Hattori¹ (1. Grad. Sch. of Med., Nagoya Univ. Nagoya, Japan)